Multivalent Forms of the Notch Ligand DLL-1 Enhance Antitumor T-Cell Immunity in Lung Cancer and Improve Efficacy of EGFR-Targeted Therapy

Cancer Research - United States
doi 10.1158/0008-5472.can-14-1154
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Combination Therapy With VEGFR2 and EGFR siRNA Enhances the Antitumor Effect of Cisplatin in Non-Small Cell Lung Cancer Xenografts

Oncology Reports
MedicineCancer ResearchOncology
2012English

Oxymatrine and Cisplatin Synergistically Enhance Anti-Tumor Immunity of CD8+ T Cells in Non-Small Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

Lung Adenocarcinoma: Guiding EGFR-targeted Therapy and Beyond

Modern Pathology
Forensic MedicinePathology
2008English

Proteogenomic Systems Analysis Identifies Targeted Therapy Resistance Mechanisms in EGFR-mutated Lung Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

P2.04-04 Expression of Intratumoral Programmed Cell Death-Ligand 1 (PD-L1) and Intratumoral CD4+T Cell, CD8+T Cell and FOXP3+T Cell in Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Development of CAR T Cells Designed to Improve Antitumor Efficacy and Safety

Pharmacology and Therapeutics
Pharmacology
2017English

Targeted Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Antitumor Effects of the Silencing of Programmed Cell Death Ligand�1 in Colorectal Cancer via Immunoregulation

Oncology Reports
MedicineCancer ResearchOncology
2018English

A Decade of Targeted Therapy for Non-Small Cell Lung Cancer

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy